In vitro, stimulation of microvascular endothelial cells with plasma collected from T1D patients with DKA led to enhanced neutrophil - endothelial cell adhesion, and this was prevented by the application of antibodies against CXCL1/8 or CXCR1/2 blockers. The gene discussed is CXCL1; the disease is type 1 diabetes mellitus.